Survival, Functional Capacity and Quality of Life after Transcatheter Aortic Valve Implantation: Present Considerations and Future Perspectives
References
- Carabello BA, Paulus WJ. Aortic stenosis. Lancet. 2009;373(9667):956–966. doi:10.1016/S0140-6736(09)60211-7
- Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;38(36):2739–2786. doi:10.1093/eurheartj/ehx391
- Cahill TJ, Chen M, Hayashida K, et al. Transcatheter aortic valve implantation: Current status and future perspectives. Eur Heart J. 2018;39(28):2625–2634. doi:10.1093/eurheartj/ehy244
- Zelis JM, van ’t Veer M, Houterman S, Pijls NHJ, Tonino PAL. Survival and quality of life after transcatheter aortic valve implantation relative to the general population. IJC Hear Vasc. 2020;28:100536. doi:10.1016/j.ijcha.2020.100536
- Martin GP, Sperrin M, Hulme W, et al. Relative survival after transcatheter aortic valve implantation: How do patients undergoing transcatheter aortic valve implantation fare relative to the general population? J Am Heart Assoc. 2017;6(10). doi:10.1161/JAHA.117.007229
- Leon MB, Smith CR, Mack M, et al. Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery. n engl j med. 2010;17:1597–1607. doi:10.1056/NEJMoa1008232
- Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients. N Engl J Med. 2011;364(23):2187–2198. doi:10.1056/NEJMoa1103510
- Baron SJ, Magnuson EA, Lu M, et al. Health Status After Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients With Aortic Stenosis. Published online 2019. doi:10.1016/j.jacc.2019.09.007
- Hall M, Alabas OA, Dondo TB, Jernberg T, Gale CP. Use of relative survival to evaluate non-ST-elevation myocardial infarction quality of care and clinical outcomes. doi:10.1093/ehjqcco/qcv011
- Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City cardiomyopathy questionnaire: A new health status measure for heart failure. J Am Coll Cardiol. 2000;35(5):1245–1255. doi:10.1016/S0735-1097(00)00531-3
- Spertus JA, Winder JA, Dewhurst TA, et al. Development and evaluation of the Seattle Angina questionnaire: A new functional status measure for coronary artery disease. J Am Coll Cardiol. 1995;25(2):333–341. doi:10.1016/0735-1097(94)00397-9
- Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan. Am Heart J. 1992;124(4):1017–1025. doi:10.1016/0002-8703(92)90986-6
- Frank D, Kennon S, Bonaros N, et al. Open access Trial protocol for the validation of the ‘Toronto Aortic Stenosis Quality of Life (TASQ) Questionnaire’ in patients undergoing surgical aortic valve replacement (SAVR) or transfemoral (TF) transcatheter aortic valve implantation (TAVI): the TASQ registry. Open Hear. 2019;6:1008. doi:10.1136/openhrt-2019-001008
- Devins GM. Using the Illness Intrusiveness Ratings Scale to understand health-related quality of life in chronic disease. J Psychosom Res. 2010;68(6):591–602. doi:10.1016/j.jpsychores.2009.05.006
- Ware JE, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: Construction of Scales and Preliminary Tests of Reliability and Validity. Med Care. 1996;34(3):220–233. doi:10.1097/00005650-199603000-00003
- Spertus JA, Jones PG, Sandhu AT, Arnold S V. Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;76(20):2379–2390. doi:10.1016/j.jacc.2020.09.542
- Styra R, Dimas M, Svitak K, et al. Toronto aortic stenosis quality of life questionnaire (TASQ): Validation in TAVI patients. BMC Cardiovasc Disord. 2020;20(1). doi:10.1186/s12872-020-01477-2
- Goudzwaard JA, De Ronde-Tillmans MJAG, Van Hoorn FED, et al. Impact of frailty on health-related quality of life 1 year after transcatheter aortic valve implantation. Age Ageing. 2020;49:989–994. doi:10.1093/ageing/afaa071
- Buckinx F, Rolland Y, Reginster JY, Ricour C, Petermans J, Bruyère O. Burden of frailty in the elderly population: Perspectives for a public health challenge. Arch Public Heal. 2015;73(1). doi:10.1186/s13690-015-0068-x
- Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: Evidence for a phenotype. Journals Gerontol - Ser A Biol Sci Med Sci. 2001;56(3). doi:10.1093/gerona/56.3.m146
- Wilke Fallerid J, Do D, Pereira N, et al. Instruments for the detection of frailty syndrome in older adults: A systematic review. Published online 2019. doi:10.1371/journal.pone.0216166
- Tocchi C, McCorkle R, Dixon J. Frailty determinants in two long-term care settings: Assistant living facilities and home and community-based programs. Home Health Care Serv Q. 2017;36(3–4):113–126. doi:10.1080/01621424.2016.1264342
- Tocchi C. The Frailty Index for Elders (FIFE). Accessed June 20, 2021.
www.ConsultGeriRN.org . - Biermann J, Horack M, Kahlert P, et al. The impact of transcatheter aortic valve implantation on quality of life: results from the German transcatheter aortic valve interventions registry. Clin Res Cardiol. 2015;104(10):877–886. doi:10.1007/s00392-015-0857-9
- Goudzwaard JA, de Ronde-Tillmans MJAG, El Faquir N, et al. The Erasmus Frailty Score is associated with delirium and 1-year mortality after Transcatheter Aortic Valve Implantation in older patients. The TAVI Care & Cure program. Int J Cardiol. 2019;276:48–52. doi:10.1016/j.ijcard.2018.10.093
- Green P, Woglom AE, Genereux P, et al. The impact of frailty status on survival after transcatheter aortic valve replacement in older adults with severe aortic stenosis: A single-center experience. JACC Cardiovasc Interv. 2012;5(9):974–981. doi:10.1016/j.jcin.2012.06.011
- Green P, Arnold S V., Cohen DJ, et al. Relation of Frailty to Outcomes After Transcatheter Aortic Valve Replacement (from the PARTNER Trial). Am J Cardiol. 2015;116(2):264–269. doi:10.1016/j.amjcard.2015.03.061
- Purba FD, Hunfeld JAM, Iskandarsyah A, et al. Employing quality control and feedback to the EQ-5D-5L valuation protocol to improve the quality of data collection. Qual Life Res. 2017;26(5):1197–1208. doi:10.1007/s11136-016-1445-9
- Barbanti M, Gargiulo G, Tamburino C. Renal dysfunction and trans-catheter aortic valve implantation outcomes. Expert Rev Cardiovasc Ther. 2016;14(12):1315–1323. doi:10.1080/14779072.2016.1234377
- Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients with Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:E72–E227. doi:10.1161/CIR.0000000000000923
- Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients. N Engl J Med. 2019;380(18):1706–1715. doi:10.1056/nejmoa1816885
- Mack MJ, Leon MB, Thourani VH, et al. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019;380(18):1695–1705. doi:10.1056/nejmoa1814052
DOI: https://doi.org/10.47803/rjc.2021.31.2.319 | Journal eISSN: 2734-6382 | Journal ISSN: 1220-658X
Language: English, French, Romanian
Page range: 319 - 325
Published on: May 3, 2022
Published by: Romanian Society of Cardiology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2022 Crina-Ioana Radulescu, Dan Deleanu, Ovidiu Chioncel, published by Romanian Society of Cardiology
This work is licensed under the Creative Commons Attribution 4.0 License.